Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

YmAbs

YmAbs?uq=AFYHfsyn
2014 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
YMAB STOCK SYMBOL
$20.81 SHARE PRICE (As of Friday Closing)
Description

Developer of monoclonal antibody therapies created to drive multiple product candidates for the treatment of for pediatric cancers. The company's lead antibody programs target GD2 and B7-H3 and utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies, enabling doctors to reduce longer-term toxicities associated with current chemotherapeutics and provide the potential for curative therapy even for patients with widespread disease.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 230 Park Avenue
  • Suite 3350
  • New York, NY 10169
  • United States

+1 (212) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore YmAbs’s full profile, request a free trial.

YmAbs Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$20.81 - $28.92 $757M $22.15 296K 34.2M

YmAbs Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
EBITDA (30,862) (19,161) (17,057)
Net Income (30,868) (19,161) (17,057)
Total Assets 73,298 92,127 17,261
Public Fundamental Data provided by Morningstar, Inc. disclaimer

YmAbs Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore YmAbs‘s full profile, request access.

Request full access to PitchBook

YmAbs Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore YmAbs‘s full profile, request access.

Request full access to PitchBook

YmAbs Executive Team (6)

Name Title Board
Seat
Contact
Info
Claus Moller Ph.D Chief Executive Officer & Board Member
Thomas Gad Founder, President, Head of Business Development & Strategy, Chairman and Founder
Bo Kruse Chief Financial Officer, Treasurer, Secretary and Board Member
Joris Wilms Chief Operating Officer, Operations & Senior Vice President
Torben Lund-Hansen Ph.D Senior Vice President, Head of Technical Operations and Board Member
You’re viewing 5 of 6 executives. Get the full list »

YmAbs Board Members (7)

Name Representing Role Since Contact
Info
Ashutosh Tyagi Self Board Member 000 0000
Claus Moller Ph.D YmAbs Chief Executive Officer & Board Member 000 0000
David Gill Self Board Member 000 0000
Gregory Raskin MD Self Board Member 000 0000
James Healy MD Sofinnova Ventures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »